Gnosis by Lesaffre announces rebranding of its chondroitin sulfate supplement for joint health

Image courtesy of Gnosis by Lesaffre

In an April 2, 2025, press release, Gnosis by Lesaffre announced a rebranding of its chondroitin sulfate. The new name, MyCondro (previously Mythocondro, launched in 2016) is intended to better recognize its efficacy with consumers and includes a new logo. As noted in the press release, chondroitin sulfate is a structural element of cartilage, bones, and connective tissue, helping maintain its function and health. In explaining the meaning behind the new, shorter name, Gnosis stated that the “My” refers to its closeness to human chondroitin sulfate and “condro” refers to the chondroitin sulfate molecule itself, made through an animal-free process.

Two pharmacokinetic studies have previously demonstrated the bioavailability of the MyCondro compared with animal-derived chondroitin sulfate¹, and additionally, two clinical studies also demonstrated its efficacy at 600 mg per day².

“Chondroitin sulfate from our sustainable, patented fermentation process delivers a highly reliable and reproducible bioactive,” explained Kimmo Makinen, Gnosis by Lesaffre head of scientific affairs, in the press release.

As Xavier Berger, global market manager, mobility & joint health, explained, concerns over the safety and consistency of conventional, animal-derived chondroitin sulfates had emerged in the industry over the years, resulting in a shift toward consumers across demographics in desiring more efficacious and environmentally conscious supplements.

“There is an increasing demand for more efficacious, more sustainable, and more convenient solutions,” stated Berger. “This is especially driven by consumers becoming more aware and informed about traditional animal-based sourcing methods, which can lead to heterogeneity, low quality, risk of contamination and adulteration. As a result, the market seeks alternative, high-quality, and reliable solutions to address these evolving consumer needs and concerns around joint health supplements.”

Through its fermentation process, MyCondro offers a different option for consumers in this market, and reportedly the only chondroitin sulfate from fermentation.

“Our chondroitin is anchored in our commitment to corporate social responsibility as we leverage fermentation and the power of micro-organisms to deliver an efficacious and planet-friendly solution,” added Berger. “MyCondro is a new brand name for a new era with sustainable chondroitin sulfate from fermentation to develop safer, more efficacious, and versatile answers for joint health and beyond. This is a long-term solution that benefits our customers—brand owners and CMOs—and, even more importantly, their consumers and the planet.”

References

References

1. Rondanelli, M.; Miraglia, N.; Putignano, P.; Peroni, G.; Faliva, MA.; Naso, M.; Gasparri, C.; Infantino, V.; Nichetti, M.; Volpi, N.; Capitani, F.; Mantovani, V.; Perna, S. Short- and Long-Term Effectiveness of Supplementation with Non-Animal Chondroitin Sulphate on Inflammation, Oxidative Stress and Functional Status in Obese Subjects with Moderate Knee Osteoarthritis before and after Physical Stress: A Randomized, Double-Blind, Placebo-Controlled Trial. Antioxidants 2020, DOI: 10.3390/antiox9121241.
2. Rondanelli, M.; Braschi, V.; Gasparri, C.; Nichetti, M.; Faliva, MA; Peroni, G.; Naso, M.; Iannello, G.; Spadaccini, D.; Miraglia, N.; Putignan, P.; Alalwan, TA.; Perna, S. Effectiveness of Non-Animal Chondroitin Sulfate Supplementation in the Treatment of Moderate Knee Osteoarthritis in a Group of Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. Nutrients 2019. DOI: 10.3390/nu11092027.